Chronic Kidney Disease News

Combined SGLT2 inhibitor and GLP-1 receptor agonist therapy could provide additional cardiovascular and renal benefits for adults with type 2 diabetes, according to data from a meta-analysis published in The Lancet Diabetes & Endocrinology.

Higher urine alpha-1-microglobulin concentration may be associated with incident chronic kidney disease in patients without prevalent CKD or diabetes, according to published data.

Patients with chronic kidney disease or transplant should have ongoing access to telehealth to help manage care, according to results of a qualitative meta-analysis.

More than one in five adults in the U.S. with type 1 diabetes also have chronic kidney disease, according to findings from a brief report published in Diabetes Care.

In a study using U.S. Military Health System data, adoption of the 2021 Chronic Kidney Disease Epidemiology Collaboration equation that removes a race coefficient to determine eGFR may reclassify Black adults into more advanced CKD stages.

Patients with HIV who undergo immediate antiretroviral therapy may not experience significant differences in chronic kidney disease outcomes compared with patients who defer treatment.

In this video, Shuchi Anand, MD, MS, discusses the importance of shared decision-making and patient-provider partnerships in personalized treatment plans for chronic kidney disease.

Matrix metalloproteinase 2 may be associated with the progression of chronic kidney disease, especially in patients with low inflammation or with proteinuria, data show.

Critically ill Chinese American patients in an ICU were less likely to receive kidney replacement therapy at the end of life compared with patients researchers described as white Americans, published data show.

Novo Nordisk has stopped phase 3 clinical trials for its drug ocedurenone after it failed to meet its primary endpoint for treating uncontrolled hypertension in patients with advanced chronic kidney disease, according to a company press release.